Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20733887 | 0.92 | GPR3 (0.48) | SIGMAR1GPR3MAPTPARP14ALOX5 | |
| SCHEMBL20172777 | 0.85 | MAPT (0.39) | SIGMAR1GPR3MAPTCYP1A2CYP2D6 | |
| SCHEMBL20172866 | 0.84 | GPR3 (0.41) | GPR3MAPTCYP1A2CYP2D6PARP14 | |
| SCHEMBL20172871 | 0.83 | GPR3 (0.39) | GPR3MAPTCYP2D6PARP14ALOX5 | |
| SCHEMBL2742930 | 0.82 | GPR3 (0.42) | SIGMAR1GPR3MAPTPARP14ALOX5 | |
| SCHEMBL20172778 | 0.81 | ALOX5 (0.44) | GPR3MAPTCYP1A2PARP14ALOX5 | |
| SCHEMBL20172868 | 0.81 | GPR3 (0.38) | GPR3MAPTPARP14ALOX5ATM | |
| SCHEMBL19929767 | 0.81 | GPR3 (0.48) | SIGMAR1GPR3MAPTPARP14ALOX5 | |
| SCHEMBL20172776 | 0.81 | MAPT (0.38) | SIGMAR1GPR3MAPTPARP14DHFR | |
| SCHEMBL20650288 | 0.81 | GPR3 (0.41) | SIGMAR1GPR3MAPTCYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | SIGMAR1 1467/4885GPR3 2049/4885MAPT 754/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | SIGMAR1 1467/4885GPR3 2049/4885MAPT 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.